| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |